On ECHEMI
Home > Drugs > Guangzhou Huahai Pharmaceutical Co., Ltd.
Guangzhou Huahai Pharmaceutical Co., Ltd.
  • Founded in:

    2002-04-08
  • Country:

    China China
  • Address:

    Floor 6, Zone C, Guangzhou Science and Technology Innovation Base, No. 80, Lanyue Road, Science City, Guangzhou Economic and Technological Development Zone
  • Tax NO.:

    914401017371578704
  • Registered Funds:

    12.1 million yuan
  • Email:

Related Drugs
Qianbai rhinitis tablets
Senecio, Selaginella, Notopterygium wilfordii, Cassia seed, Ephedra, Ligusticum chuanxiong, Angelica dahurica.
Name Description Content CAS NO. Registered Holders
Climbing Groundsel Herb

0
SELAGINELLAE HERBA

0
RHIZOMA ET RADIX NOTOPTERYGII

0
CASSIAE SEMEN

0
Ephedra

0
Riligustilide

89354-45-0 0
Angelicae Dahuricae Radix

0
Cold Clearing Tablets
Root of Isatis indigotica, folium isatidis, calendula officinalis, rhizoma atractylodis macrocephala, sesame, acetaminophen, andrographolide leaf, guanidine hydrochloride, chlorpheniramine maleate.
Name Description Content CAS NO. Registered Holders
BAPHICACANTHIS CUSIAE RHIZOMA ET RADIX

0
ISATIDIS FOLIUM

0
HERBA BIDENTIS

0
Gangmei

0
mountain sesame

0
Acetaminophen

103-90-2 68
Andrographis leaf superfine powder

0
Moroxydine hydrochloride

3160-91-6 12
Chlorphenamine maleate

113-92-8 28
Metronidazole chlorhexidine lotion
This product is a compound preparation, each milliliter contains the main ingredients chlorhexidine gluconate and metronidazole.
Name Description Content CAS NO. Registered Holders
Chlorhexidine digluconate

Broad spectrum fungicide

More

Broad spectrum fungicide

18472-51-0 31
Metronidazole

Anti-anaerobic bacteria, anti-trichomoniasis

More

Anti-anaerobic bacteria, anti-trichomoniasis

443-48-1 39
Compound South Isatis Root Tablets
Southern isatis root, Viola yedoensis, and dandelion.
Name Description Content CAS NO. Registered Holders
BAPHICACANTHIS CUSIAE RHIZOMA ET RADIX

0
Purpleflower Violet

0
Taraxasterol

0
Sulfadiazine Tablets
Sulfadiazine
Name Description Content CAS NO. Registered Holders
Sulfadiazine

This product is a medium-acting sulfonamide. It has antibacterial effects on non-enzyme-producing Staphylococcus aureus, Streptococcus pyogenes, Streptococcus pneumoniae, Escherichia coli, Klebsiella, Salmonella, Shigella and other Enterobacteriaceae, gonococci, meningococci, Haemophilus influenzae. In addition, it also has antimicrobial activity against Chlamydia trachomatis, Nocardia asteroides, Plasmodium and Toxoplasma in vitro. The antibacterial activity of this product is the same as that of sulfamethoxazole. However, in recent years, bacterial resistance to this product has increased, especially Streptococcus, Neisseria and Enterobacteriaceae. Sulfonamides are broad-spectrum antibacterial agents. This product is similar in structure to para-aminobenzoic acid (PABA), and can compete with PABA on dihydrofolate synthase in bacteria, thereby preventing PABA from being used as a raw material to synthesize folic acid required by bacteria, reducing the amount of metabolically active tetrahydrofolate, which is an essential substance for bacteria to synthesize purine, thymidine and deoxyribonucleic acid (DNA), thereby inhibiting the growth and reproduction of bacteria.

More

This product is a medium-acting sulfonamide. It has antibacterial effects on non-enzyme-producing Staphylococcus aureus, Streptococcus pyogenes, Streptococcus pneumoniae, Escherichia coli, Klebsiella, Salmonella, Shigella and other Enterobacteriaceae, gonococci, meningococci, Haemophilus influenzae. In addition, it also has antimicrobial activity against Chlamydia trachomatis, Nocardia asteroides, Plasmodium and Toxoplasma in vitro. The antibacterial activity of this product is the same as that of sulfamethoxazole. However, in recent years, bacterial resistance to this product has increased, especially Streptococcus, Neisseria and Enterobacteriaceae. Sulfonamides are broad-spectrum antibacterial agents. This product is similar in structure to para-aminobenzoic acid (PABA), and can compete with PABA on dihydrofolate synthase in bacteria, thereby preventing PABA from being used as a raw material to synthesize folic acid required by bacteria, reducing the amount of metabolically active tetrahydrofolate, which is an essential substance for bacteria to synthesize purine, thymidine and deoxyribonucleic acid (DNA), thereby inhibiting the growth and reproduction of bacteria.

68-35-9 14
  • 1
  • 2
  • Go to Page Go
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.